288 related articles for article (PubMed ID: 8192414)
1. Routine determination of biliary lipid composition with the entero-test.
Muraca M; Pazzi P; Vilei MT; Miconi L; Granato A; Cianci V; Sighinolfi D; Alvisi A; Gerunda G; Maffei Faccioli A
Ann Chir; 1994; 48(2):197-200. PubMed ID: 8192414
[TBL] [Abstract][Full Text] [Related]
2. Effects of biliary bile acid composition on biliary cholesterol saturation in gallstone patients treated with chenodeoxycholic acid and/or ursodeoxycholic acid.
Stiehl A; Raedsch R; Czygan P; Götz R; Männer C; Walker S; Kommerell B
Gastroenterology; 1980 Dec; 79(6):1192-8. PubMed ID: 7439628
[TBL] [Abstract][Full Text] [Related]
3. Effect of litholytic bile acids on cholesterol absorption in gallstone patients.
LaRusso NF; Thistle JL
Gastroenterology; 1983 Feb; 84(2):265-71. PubMed ID: 6848406
[TBL] [Abstract][Full Text] [Related]
4. Changes of bile acid and lipid composition in blood and bile in the clinical course after the initiation of cheno- and ursodeoxycholic acid therapy in patients with cholesterol gallstones.
Iwamura K
Tokai J Exp Clin Med; 1982 Nov; 7(6):671-83. PubMed ID: 7184199
[TBL] [Abstract][Full Text] [Related]
5. The effects of the 3-hydroxy, 3-methylglutaryl coenzyme A reductase inhibitor pravastatin on bile composition and nucleation of cholesterol crystals in cholesterol gallstone disease.
Smit JW; van Erpecum KJ; Renooij W; Stolk MF; Edgar P; Doornewaard H; Vanberge-Henegouwen GP
Hepatology; 1995 Jun; 21(6):1523-9. PubMed ID: 7768495
[TBL] [Abstract][Full Text] [Related]
6. Total protein content of human gallbladder bile: relation to cholesterol gallstone disease and effects of treatment with bile acids and aspirin.
Sahlin S
Eur J Surg; 1996 Jun; 162(6):463-9. PubMed ID: 8817223
[TBL] [Abstract][Full Text] [Related]
7. Determination of gallbladder bile lithogenicity in patients with primary biliary cirrhosis.
Fracchia M; Jazrawi RP; Galatola G
Ital J Gastroenterol; 1996 Jun; 28(5):255-60. PubMed ID: 8842843
[TBL] [Abstract][Full Text] [Related]
8. Effect of administration of ursodeoxycholic acid at bedtime on cholesterol saturation of hepatic bile in Japanese patients with gallstone.
Inoi J; Shimizu I; Tsuji Y; Muguruma N; Shibata H; Ito S
J Med Invest; 1998 Aug; 45(1-4):115-22. PubMed ID: 9864972
[TBL] [Abstract][Full Text] [Related]
9. [Changes in the pattern of serum biliary acids and lipoprotein picture during therapy with biliary acids in cholesterol lithiasis].
Di Mario F; Angonese C; Del Favero G; Aggio L; Meggiato T; Scalon P; Basso D; Plebani M; Burlina A; Naccarato R
G Clin Med; 1990; 71(6-7):435-41. PubMed ID: 2258026
[TBL] [Abstract][Full Text] [Related]
10. Effect of apolipoprotein E polymorphism on bile lipid composition and the formation of cholesterol gallstone.
Hasegawa K; Terada S; Kubota K; Itakura H; Imamura H; Ohnishi S; Aoki T; Ijichi M; Saiura A; Makuuchi M
Am J Gastroenterol; 2003 Jul; 98(7):1605-9. PubMed ID: 12873586
[TBL] [Abstract][Full Text] [Related]
11. Distribution of cholesterol between vesicles and micelles in human gallbladder bile: influence of treatment with chenodeoxycholic acid and ursodeoxycholic acid.
Sahlin S; Thyberg P; Ahlberg J; Angelin B; Einarsson K
Hepatology; 1991 Jan; 13(1):104-10. PubMed ID: 1988332
[TBL] [Abstract][Full Text] [Related]
12. The effects of ursodeoxycholic acid on serum and biliary noncholesterol sterols in patients with gallstones.
Miettinen TE; Tarpila S; Gylling H
Hepatology; 1997 Mar; 25(3):514-8. PubMed ID: 9049189
[TBL] [Abstract][Full Text] [Related]
13. Biliary lipid composition in normo- and hyperlipoproteinemia.
Ahlberg J; Angelin B; Einarsson K; Hellström K; Leijd B
Gastroenterology; 1980 Jul; 79(1):90-4. PubMed ID: 7380228
[TBL] [Abstract][Full Text] [Related]
14. Combined bile acid therapy is more effective on biliary lipids and dissolution rates than monotherapy after gallstone lithotripsy.
Tudyka J; Kratzer W; Janowitz P; Mason R; Wechsler JG
Am J Gastroenterol; 1995 Nov; 90(11):1942-8. PubMed ID: 7484996
[TBL] [Abstract][Full Text] [Related]
15. Abnormal duodenal bile composition in patients with acalculous chronic cholecystitis.
Venkataramani A; Strong RM; Anderson DS; Gilmore IT; Stokes K; Hofmann AF
Am J Gastroenterol; 1998 Mar; 93(3):434-41. PubMed ID: 9517653
[TBL] [Abstract][Full Text] [Related]
16. Pathogenesis of human cholesterol cholelithiasis.
Strasberg SM; Fisher MM
Can Med Assoc J; 1975 Feb; 112(4):484-8. PubMed ID: 1089468
[TBL] [Abstract][Full Text] [Related]
17. Effect of chenodeoxycholic acid and ursodeoxycholic acid administration on acyl-CoA: cholesterol acyltransferase activity in human liver.
Abate N; Carubbi F; Bozzoli M; Bertolotti M; Farah I; Rosi A; Carulli N
Ital J Gastroenterol; 1994; 26(6):287-93. PubMed ID: 7949265
[TBL] [Abstract][Full Text] [Related]
18. Clinical perspective on the treatment of gallstones with ursodeoxycholic acid.
Salen G
J Clin Gastroenterol; 1988; 10 Suppl 2():S12-7. PubMed ID: 3062079
[TBL] [Abstract][Full Text] [Related]
19. Behavior of various cholesterol crystals in bile from patients with gallstones.
Portincasa P; van Erpecum KJ; Jansen A; Renooij W; Gadellaa M; vanBerge-Henegouwen GP
Hepatology; 1996 Apr; 23(4):738-48. PubMed ID: 8666327
[TBL] [Abstract][Full Text] [Related]
20. Comparative evaluation of chenodeoxycholic and ursodeoxycholic acids in obese patients. Effects on biliary lipid metabolism during weight maintenance and weight reduction.
Mazzella G; Bazzoli F; Festi D; Ronchi M; Aldini R; Roda A; Grigolo B; Simoni P; Villanova N; Roda E
Gastroenterology; 1991 Aug; 101(2):490-6. PubMed ID: 2065925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
